DPEP1 and focal segmental glomerulosclerosis: Future metabolomics studies on the concentration level of LTC4/LTD4 and TRPC6 activity can evaluate the hypothesis of implication of DPEP1 deficiency in the pathogenesis of FSGS and a role for antileukotrienes (e.g., indomethacin) in treatment of FSGS.